LifeStance Health Group, Inc. (LFST) is a publicly traded company in the Healthcare — Medical - Care Facilities industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions.
Is LifeStance Health Group, Inc. stock overvalued or undervalued in 2026?
LifeStance Health Group, Inc. (LFST) trades at 105× earnings (P/E), above the median of the 246 healthcare companies over $2bn in Kaplio's universe. At its sector median (30.4×) $4 (-71 %).
Kaplio overview: LifeStance Health Group, Inc.
Market cap $5B · 52 weeks $5 – $13 (0 % below the high) · P/E 105× · 2027 expected P/E 62.1× · Dividend none · Next earnings November 5, 2026 · expected EPS $0.04 · Closing price, Oct 29 · accounts published Aug 6.
- Valuation: P/E 105.1× (expensive).
- Business: ROIC 3 % (weak).
- Balance sheet: Net cash/EBITDA 0.7× (solid).
- Earnings: 8 of 8 (on track).
What would it be worth at its usual multiples?
At its sector median (30.4×) $4 (-71 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
What matters in pharma: 2 of 5 pass
- R&D / Revenue 0.0 %, fails.
- Gross margin 32.4 %, fails.
- ROIC 3.0 %, fails.
- FCF / Net Income 1,138.6 %, passes.
- Net debt / EBITDA −0.7×, passes.
Against its peers (reference peers) — LifeStance Health Group, Inc.: P/E 105×; EV/EBITDA 37.8×; ROIC 3.0 %; $5.2B. Universal Health Services, Inc. (P/E 7.4×; EV/EBITDA 5.4×; ROIC 10.4 %; $9.1B), Privia Health Group, Inc. (P/E 101×; EV/EBITDA —; ROIC 0.0 %; $2.8B), BrightSpring Health Services, Inc. Common Stock (P/E 44.9×; EV/EBITDA 21.3×; ROIC 8.9 %; $11.9B).
Profitability
| Return on Equity | 3.39% |
| Return on Invested Capital | 3.03% |
| Return on Assets | 2.32% |
| Gross Margin | 33.56% |
| Operating Margin | 4.95% |
| Net Margin | 3.19% |
Financial Health
| Debt / Equity | 0.14 |
| Current Ratio | 1.38 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 2.65 |
Price Performance
| 1 month | +11.31% |
| 3 months | +27.77% |
| Year-to-date | +90.20% |
| 1 year | +172.71% |
| 3 years | +129.67% |
| 5 years | +11.77% |
Related companies: BTSG · PRVA · ACHC · UHS · HIMS
Explore sector: Healthcare · Medical - Care Facilities
More sections of LFST: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks